Zydus receives final approval from USFDA for Vigabatrin Tablets
NEW DELHI: Zydus has received final approval from the USFDA to market Vigabatrin Tablets in the strength of 500 mg...
USFDA
Alembic Pharmaceuticals gets USFDA nod to market generic product
NEW DELHI: Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market generic Dronedarone...
Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA
NEW DELHI: Zydus Cadila has received final approval from the USFDA to market Nelarabine Injection 250MG/50ML in the United States...
Zydus Cadila receives tentative approval from USFDA for Eluxadoline Tablets
NEW DELHI: Zydus Cadila's U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received tentative approval from the USFDA to market Eluxadoline...
Zydus Cadila gets USFDA’s approval to market diabetes medication
NEW DELHI: Drug firm Zydus Cadila on Monday said it has received approval from the US health regulator to market...
Zydus Cadila gets USFDA nod for arthritis drug with 180-days exclusivity
NEW DELHI: Drug firm Zydus Cadila on Monday said it has received final approval from the US health regulator to...
Glenmark Pharma gets USFDA approval for generic lung cancer drug
NEW DELHI: Glenmark Pharmaceuticals on Friday said it has received approval from the US health regulator to market Nintedanib capsules,...
Cipla gets USFDA nod for inhalation product
NEW DELHI: Drug major Cipla on Wednesday said it has received final approval from the US health regulator for Arformoterol...
Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets
NEW DELHI: Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10...
Natco Pharma gets USFDA nod for generic cancer treatment drug
NEW DELHI: Natco Pharma on Saturday said it has received approval from the US health regulator for generic Lenalidomide capsules...
